4.6 Article

Type I diabetes mellitus decreases in vivo macrophage-to-feces reverse cholesterol transport despite increased biliary sterol secretion in mice

Journal

JOURNAL OF LIPID RESEARCH
Volume 53, Issue 3, Pages 348-357

Publisher

ELSEVIER
DOI: 10.1194/jlr.M018671

Keywords

high density lipoproteins; bile acids; cardiovascular disease; atherosclerosis; neutral sterols; glucose; efflux; selective uptake; liver; bile

Funding

  1. Netherlands Organization for Scientific Research [917-56-358]
  2. Top Institute (TI) Food and Nutrition
  3. Groningen Expert Center for Kids with Obesity

Ask authors/readers for more resources

Type I diabetes mellitus (T1DM) increases atherosclerotic cardiovascular disease; however, the underlying pathophysiology is still incompletely understood. We investigated whether experimental T1DM impacts HDL-mediated reverse cholesterol transport (RCT). C57BL/6J mice with alloxan-induced T1DM had higher plasma cholesterol levels (P < 0.05), particularly within HDL, and increased hepatic cholesterol content (P < 0.001). T1DM resulted in increased bile flow (2.1-fold; P < 0.05) and biliary secretion of bile acids (BA, 10.5-fold; P < 0.001), phospholipids (4.5-fold; P < 0.001), and cholesterol (5.5-fold; P < 0.05). Hepatic cholesterol synthesis was unaltered, whereas BA synthesis was increased in T1DM (P < 0.001). Mass fecal BA output was significantly higher in T1DM mice (1.5-fold; P < 0.05), fecal neutral sterol excretion did not change due to increased intestinal cholesterol absorption (2.1-fold; P < 0.05). Overall in vivo macrophage-to-feces RCT, using [H-3] cholesterol-loaded primary mouse macrophage foam cells, was 20% lower in T1DM (P < 0.05), mainly due to reduced tracer excretion within BA (P < 0.05). In vitro experiments revealed unchanged cholesterol efflux toward T1DM HDL, whereas scavenger receptor class BI-mediated selective uptake from T1DM HDL was lower in vitro and in vivo (HDL kinetic experiments) (P < 0.05), conceivably due to increased glycation of HDL-associated proteins (+65%, P < 0.01). In summary, despite higher mass biliary sterol secretion T1DM impairs macrophage-to-feces RCT, mainly by decreasing hepatic selective uptake, a mechanism conceivably contributing to increased cardiovascular disease in T1DM.-Freark de Boer, J., W. Annema, M. Schreurs, J. N. van der Veen, M. van der Giet, N. Nijstad, F. Kuipers, and U. J. F. Tietge. Type I diabetes mellitus decreases in vivo macrophage-to-feces reverse cholesterol transport despite increased biliary sterol secretion in mice. J. Lipid Res. 2012. 53: 348-357.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Multidisciplinary Sciences

Mice with a deficiency in Peroxisomal Membrane Protein 4 (PXMP4) display mild changes in hepatic lipid metabolism

Maaike Blankestijn, Vincent W. Bloks, Dicky Struik, Nicolette Huijkman, Niels Kloosterhuis, Justina C. Wolters, Ronald J. A. Wanders, Frederic M. Vaz, Markus Islinger, Folkert Kuipers, Bart van de Sluis, Albert K. Groen, Henkjan J. Verkade, Johan W. Jonker

Summary: The study of a Pxmp4 knockout mouse model suggests that PXMP4 is not critical for overall peroxisome function but may have a role in the metabolism of (ether)lipids.

SCIENTIFIC REPORTS (2022)

Review Medicine, General & Internal

Modulation of Bile Acid Metabolism to Improve Plasma Lipid and Lipoprotein Profiles

Boyan Zhang, Folkert Kuipers, Jan Freark de Boer, Jan Albert Kuivenhoven

Summary: This review evaluates the potential of new drugs targeting bile acid metabolism in the treatment of cholestatic liver diseases, NAFLD, and NASH. The review also explores the impact of changes in bile acid metabolism on plasma cholesterol, triglycerides, and cardiovascular outcomes. The findings highlight the need for further research on the interactions between bile acid and lipid and lipoprotein metabolism.

JOURNAL OF CLINICAL MEDICINE (2022)

Letter Gastroenterology & Hepatology

Response to Spontaneous Cholemia in C57BL/6 Mice Predisposes to Liver Cancer in NASH

Onne A. H. O. Ronda, Vincent W. Bloks, Jan-Freark De Boer, Folkert Kuipers, Henkjan J. Verkade

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Pediatrics

Perinatal exposure to UDCA prevents neonatal cholestasis in Cyp2c70-/- mice with human-like bile acids

Hilde D. de Vries, Anna Palmiotti, Rumei Li, Milaine Hovingh, Niels L. Mulder, Martijn Koehorst, Vincent W. Bloks, Tim van Zutphen, Folkert Kuipers, Jan Freark de Boer

Summary: Perinatal exposure to UDCA can prevent neonatal cholestasis in Cyp2c70(-/-) mice, but has no long-lasting effects on liver pathophysiology.

PEDIATRIC RESEARCH (2023)

Article Biochemistry & Molecular Biology

Role of bile acid receptor FXR in development and function of brown adipose tissue

J. Yang, H. D. de Vries, A. Mayeuf-Louchart, J. H. Stroeve, V. W. Bloks, M. Koehorst, H. Duez, B. Staels, F. Kuipers, T. van Zutphen

Summary: Bile acids, acting through the G-protein-coupled receptor TGR5, play a role in energy homeostasis in mice and humans. However, the role of the nuclear bile acid receptor FXR in brown adipose tissue (BAT) has been unclear. This study demonstrates that moderate adipose tissue-specific overexpression of FXR in mice leads to whitening of BAT, with changes in lipid droplets, collagen deposition, and gene expression. These findings suggest that bile acid signalling via FXR is involved in BAT function during tissue development, and may oppose the thermogenic effects mediated by TGR5.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2023)

Article Biochemistry & Molecular Biology

Identification of Side Chain Oxidized Sterols as Novel Liver X Receptor Agonists with Therapeutic Potential in the Treatment of Cardiovascular and Neurodegenerative Diseases

Na Zhan, Boyang Wang, Nikita Martens, Yankai Liu, Shangge Zhao, Gardi Voortman, Jeroen Van Rooij, Frank Leijten, Tim Vanmierlo, Folkert Kuipers, Johan W. Jonker, Vincent W. Bloks, Dieter Luetjohann, Marcella Palumbo, Francesca Zimetti, Maria Pia Adorni, Hongbing Liu, Monique T. Mulder

Summary: The study identified five novel LXR-activating 24-oxidized sterols with potential therapeutic applications in neurodegenerative and cardiovascular diseases. These compounds demonstrated high potency for LXR alpha/beta activation and induced the expression of LXR-target genes involved in cellular cholesterol turnover. They also enhanced cholesterol efflux and upregulated the production of endogenous LXR agonists. Overall, these findings suggest the potential of developing compounds targeting LXR for the treatment of lipid-related diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Endocrinology & Metabolism

Adipocyte-specific FXR-deficiency protects adipose tissue from oxidative stress and insulin resistance and improves glucose homeostasis

Arianna Marino, Laura Butruille, Denis A. Mogilenko, Arielle C. Nzoussi Loubota, Oscar Chavez-Talavera, Emilie Dorchies, Emmanuelle Vallez, Joel Haas, Bruno Derudas, Antonino Bongiovanni, Meryem Tardivel, Folkert Kuipers, Philippe Lefebvre, Sophie Lestavel, Anne Tailleux, David Dombrowicz, Sandrine Caron, Bart Staels

Summary: This study reveals the regulatory role of FXR in adipose tissue function in obese rats, improving glucose metabolism and systemic oxidative stress by inhibiting inflammatory responses and enhancing insulin sensitivity. Transcriptomic analysis identified the Gsta4 gene as the most upregulated gene in Ad-FXR-/- mouse adipocytes.

MOLECULAR METABOLISM (2023)

Article Biochemistry & Molecular Biology

Intestinal Farnesoid X Receptor Modulates Duodenal Surface Area but Does Not Control Glucose Absorption in Mice

Jiufang Yang, Theo H. van Dijk, Martijn Koehorst, Rick Havinga, Jan Freark de Boer, Folkert Kuipers, Tim van Zutphen

Summary: Bile acids are involved in the absorption of dietary lipids and serve as signaling molecules for metabolic homeostasis. FXR, a nuclear receptor responsive to bile acids, has been implicated in bile acid metabolism and lipid and glucose homeostasis. However, this study found that intestinal FXR does not play a role in glucose absorption, but does affect small intestinal surface area.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Nutrition & Dietetics

Emerging Roles of Gut Microbial Modulation of Bile Acid Composition in the Etiology of Cardiovascular Diseases

Tess Yntema, Debby P. Y. Koonen, Folkert Kuipers

Summary: Despite advancements in prevention and treatment, cardiovascular disease (CVD) remains the leading cause of death worldwide. Recent studies have highlighted the potential role of non-traditional factors, such as the gut microbiota and its metabolites, in CVD. Specifically, disturbances in the gut microbiota and altered bile acid metabolism have been associated with CVD development. Bile acids, apart from their role in lipid absorption and metabolism, have been found to act as signaling molecules and modulate cardiometabolic pathways, making them potential therapeutic targets in CVD.

NUTRIENTS (2023)

Article Medicine, Research & Experimental

Gut microbiota depletion aggravates bile acid-induced liver pathology in mice with a human-like bile acid composition

Esther Verkade, Wenqiang Shen, Milaine Hovingh, Niels L. Mulder, Krisztina de Bruyn, Martijn Koehorst, Hilde D. de Vries, Vincent W. Bloks, Folkert Kuipers, Jan Freark de Boer

Summary: This study suggests that depletion of gut microbiota in Cyp2c70-/- mice aggravates liver pathology by increasing the hydrophobicity of the circulating bile acid pool. Additionally, the impact of antibiotic treatment on Cyp2c70-/- mice differs between genders, with more severe effects observed in female mice.

CLINICAL SCIENCE (2023)

Article Medicine, Research & Experimental

Absence of gut microbiota reduces neonatal survival and exacerbates liver disease in Cyp2c70-deficient mice with a human-like bile acid composition

Wilhelm Sjoland, Annika Wahlstrom, Kassem Makki, Marc Scholer, Antonio Molinaro, Lisa Olsson, Thomas Uwe Greiner, Robert Caesar, Jan Freark de Boer, Folkert Kuipers, Fredrik Backhed, Hanns-Ulrich Marschall

Summary: Mice with deletion of Cyp2c70 exhibit features of hepatobiliary disease and can serve as a model for studying bile acid interactions in cholestatic liver disease. Germ-free Cyp2c70-/- mice showed reduced neonatal survival, liver fibrosis, and cholangiocyte proliferation. Colonization with a microbiota, particularly from conventionally raised mice, improved the liver phenotype in Cyp2c70-/- mice and was associated with changes in bile acid composition and gut microbiota.

CLINICAL SCIENCE (2023)

Article Medicine, Research & Experimental

Inhibition of DHCR24 activates LXRα to ameliorate hepatic steatosis and inflammation

Enchen Zhou, Xiaoke Ge, Hiroyuki Nakashima, Rumei Li, Hendrik J. P. van der Zande, Cong Liu, Zhuang Li, Christoph Mueller, Franz Bracher, Yassene Mohammed, Jan Freark de Boer, Folkert Kuipers, Bruno Guigas, Christopher K. Glass, Patrick C. N. Rensen, Martin Giera, Yanan Wang

Summary: DHCR24 inhibition prevents the development of NAFLD/NASH without causing hyperlipidemia. SH42, a DHCR24 inhibitor, significantly increases desmosterol levels, reduces hepatic lipid content and steatosis, and decreases plasma fatty acid and cholesteryl ester concentrations. SH42 treatment also decreases liver collagen content and plasma alanine transaminase levels.

EMBO MOLECULAR MEDICINE (2023)

Article Multidisciplinary Sciences

Hepatic SREBP signaling requires SPRING to govern systemic lipid metabolism in mice and humans

Sebastian Hendrix, Jenina Kingma, Roelof Ottenhoff, Masoud Valiloo, Monika Svecla, Lobke F. Zijlstra, Vinay Sachdev, Kristina Kovac, Johannes H. M. Levels, Aldo Jongejan, Jan F. de Boer, Folkert Kuipers, Antoine Rimbert, Giuseppe D. Norata, Anke Loregger, Noam Zelcer

Summary: SPRING is identified as a post-transcriptional regulator of SREBP activation, controlling cholesterol and fatty acid metabolism. Liver-specific knockout of Spring results in attenuated SREBP signaling, decreased plasma cholesterol, and reduced hepatic lipid content in mice. SPRING gene variants are also associated with levels of circulating HDL cholesterol and ApoA1 in humans. This study highlights the importance of SPRING in hepatic SREBP signaling and systemic lipid metabolism in both mice and humans.

NATURE COMMUNICATIONS (2023)

Article Nutrition & Dietetics

Activation of Liver X Receptors and Peroxisome Proliferator-Activated Receptors by Lipid Extracts of Brown Seaweeds: A Potential Application in Alzheimer's Disease?

Nikita Martens, Na Zhan, Gardi Voortman, Frank P. J. Leijten, Connor van Rheenen, Suzanne van Leerdam, Xicheng Geng, Michiel Huybrechts, Hongbing Liu, Johan W. W. Jonker, Folkert Kuipers, Dieter Lutjohann, Tim Vanmierlo, Monique T. T. Mulder

Summary: The nuclear liver X receptors (LXRα/β) and peroxisome proliferator-activated receptors (PPARα/γ) play a role in regulating lipid metabolism and inflammation. The activation of these receptors has neuroprotective effects and may be a potential treatment for neurodegenerative disorders like Alzheimer's Disease (AD). The brown seaweed Sargassum fusiforme contains compounds that activate these receptors and have been shown to prevent disease progression in a mouse model of AD.

NUTRIENTS (2023)

Article Medicine, Research & Experimental

Haploinsufficiency of CYP8B1 associates with increased insulin sensitivity in humans

Shiqi Zhong, Raphael Chevre, David Castano Mayan, Maria Corliano, Blake J. Cochran, Kai Ping Sem, Theo H. van Dijk, Jianhe Peng, Liang Juin Tan, Siddesh V. Hartimath, Boominathan Ramasamy, Peter Cheng, Albert K. Groen, Folkert Kuipers, Julian L. Goggi, Chester Drum, Rob M. van Dam, Ru San Tan, Kerry-Anne Rye, Michael R. Hayden, Ching-Yu Cheng, Shaji Chacko, Jason Flannick, Xueling Sim, Hong Chang Tan, Roshni R. Singaraja

Summary: Reduced CYP8B1 activity is associated with increased insulin sensitivity in humans, possibly due to increased skeletal muscle insulin sensitivity caused by increased circulating CDCA.

JOURNAL OF CLINICAL INVESTIGATION (2022)

No Data Available